Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
51.58%
operating margin TTM
4.46%
revenue TTM
60.23 Million
revenue per share TTM
1.16$
valuation ratios | |
|---|---|
| pe ratio | 16.01 |
| peg ratio | 0.05 |
| price to book ratio | 3.04 |
| price to sales ratio | 8.46 |
| enterprise value multiple | 15.54 |
| price fair value | 3.04 |
profitability ratios | |
|---|---|
| gross profit margin | 89.4% |
| operating profit margin | 4.46% |
| pretax profit margin | 56.48% |
| net profit margin | 51.58% |
| return on assets | 11.45% |
| return on equity | 19.4% |
| return on capital employed | 1.06% |
liquidity ratios | |
|---|---|
| current ratio | 13.54 |
| quick ratio | 13.54 |
| cash ratio | 7.14 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 71.32 |
| days of payables outstanding | 21.52 |
| cash conversion cycle | 49.80 |
| receivables turnover | 5.12 |
| payables turnover | 16.96 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.08 |
| debt equity ratio | 0.13 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.12 |
| interest coverage | 4.03 |
| cash flow to debt ratio | 1.34 |
cash flow ratios | |
|---|---|
| free cash flow per share | 1.00 |
| cash per share | 7.50 |
| operating cash flow per share | 1.00 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | 1.34 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | 6,478.25 |
Frequently Asked Questions
When was the last time Theravance Biopharma Inc (NASDAQ:TBPH) reported earnings?
Theravance Biopharma Inc (TBPH) published its most recent earnings results on 11-08-2026.
What is Theravance Biopharma Inc's current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Theravance Biopharma Inc (NASDAQ:TBPH)'s trailing twelve months ROE is 19.4%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Theravance Biopharma Inc (TBPH) currently has a ROA of 11.45%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did TBPH's net profit margin stand at?
TBPH reported a profit margin of 51.58% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is TBPH's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 13.54 in the most recent quarter. The quick ratio stood at 13.54, with a Debt/Eq ratio of 0.13.